Ion mobility mass spectrometry enhances low-abundance species detection in untargeted lipidomics

Metabolomics

Volumn 12, Issue 3, 2016, Pages

  Basit, Abdul ^a   Pontis, Silvia ^a   Piomelli, Daniele ^a,b   Armirotti, Andrea ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ion mobility mass spectrometry; N acyl phosphatidylethanolamines; Neuroinflammation; Untargeted lipidomics

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL BODY; CONTROLLED STUDY; IMMUNOFLUORESCENCE; ION MOBILITY SPECTROMETRY; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; SUBSTANTIA NIGRA; TISSUE INJURY;

EID: 85008440412     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-016-0971-3     Document Type: Article

References (29)

1. Armirotti, A., Basit, A., Realini, N., Caltagirone, C., Bossu, P., Spalletta, G., & Piomelli, D. (2014). Sample preparation and orthogonal chromatography for broad polarity range plasma metabolomics: Application to human subjects with neurodegen-erative dementia. Analytical Biochemistry, 455, 48–54.
2. Astarita, G., Ahmed, F., & Piomelli, D. (2008). Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. Journal of Lipid Research, 49, 48–57.
3. Astarita, G., & Piomelli, D. (2011). Towards a whole-body systems [multi-organ] lipidomics in Alzheimer’s disease. Prostaglandins Leukotrienes and Essential Fatty Acids, 85, 197–203.
4. Baker, P. R., Armando, A. M., Campbell, J. L., Quehenberger, O., & Dennis, E. A. (2014). Three-dimensional enhanced lipidomics analysis combining UPLC, differential ion mobility spectrometry, and mass spectrometric separation strategies. Journal of Lipid Research, 55, 2432–2442.
5. Basit, A., Piomelli, D., & Armirotti, A. (2015). Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS/MS. Analytical and Bioanalytical Chemistry, 407, 5189–5198.
6. Blasco, H., Corcia, P., Pradat, P. F., Bocca, C., Gordon, P. H., Veyrat-Durebex, C., et al. (2013). Metabolomics in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis: An Untargeted Approach via High-Resolution Mass Spectrometry. Journal of Proteome Research, 12, 3746–3754.
7. Blesa, J., & Przedborski, S. (2014). Parkinson’s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat, 8, 155.
8. Cajka, T., & Fiehn, O. (2014). Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Analyt Chem, 61, 192–206.
9. Esposito, E., Cordaro, M., & Cuzzocrea, S. (2014). Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. Pharmacological Research, 86, 26–31.
10. Fahy, E., Subramaniam, S., Murphy, R. C., Nishijima, M., Raetz, C. R., Shimizu, T., et al. (2009). Update of the LIPID MAPS comprehensive classification system for lipids. Journal of Lipid Research, 50(Suppl), S9–S14.
11. Guo, L., Amarnath, V., & Davies, S. S. (2010). A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines. Analytical Biochemistry, 405, 236–245.
12. Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., et al. (2011). Metabolomics in early Alzheimer’s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One, 6, e21643.
13. Hansen, H. H., Hansen, S. H., Schousboe, A., & Hansen, H. S. (2000). Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons. Journal of Neurochemistry, 75, 861–871.
14. Janfelt, C., Wellner, N., Leger, P. L., Kokesch-Himmelreich, J., Hansen, S. H., Charriaut-Marlangue, C., & Hansen, H. S. (2012). Visualization by mass spectrometry of 2-dimensional changes in rat brain lipids, including N-acylphosphatidylethanolamines, during neonatal brain ischemia. The FASEB Journal, 26, 2667–2673.
15. Le, W., Sayana, P., & Jankovic, J. (2014). Animal models of Parkinson’s disease: A gateway to therapeutics? Neurothera-peutics, 11, 92–110.
16. May, J. C., Goodwin, C. R., & McLean, J. A. (2015). Ion mobility-mass spectrometry strategies for untargeted systems, synthetic, and chemical biology. Current Opinion in Biotechnology, 31C, 117–121.
17. Morales, I., Sanchez, A., Rodriguez-Sabate, C., & Rodriguez, M. (2015). The degeneration of dopaminergic synapses in Parkinson’s disease: A selective animal model. Behavioural Brain Research, 289, 19–28.
18. Paglia, G., Angel, P., Williams, J. P., Richardson, K., Olivos, H. J., Thompson, J. W., et al. (2015). Ion mobility-derived collision cross section as an additional measure for lipid fingerprinting and identification. Analytical Chemistry, 87, 1137–1144.
19. Pedersen, A. J., Dalsgaard, P. W., Rode, A. J., Rasmussen, B. S., Muller, I. B., Johansen, S. S., & Linnet, K. (2013). Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition. Journal of Separation Science, 36, 2081–2089.
20. Ramadan, Z., Jacobs, D., Grigorov, M., & Kochhar, S. (2006). Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. Talanta, 68, 1683–1691.
21. Schmelzer, K., Fahy, E., Subramaniam, S., & Dennis, E. A. (2007). The lipid maps initiative in lipidomics. Methods in Enzymology, 432, 171–183.
22. Smith, C. A., O’Maille, G., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., et al. (2005). METLIN: A metabolite mass spectral database. Therapeutic Drug Monitoring, 27, 747–751.
23. Song, H., Hsu, F. F., Ladenson, J., & Turk, J. (2007). Algorithm for processing raw mass spectrometric data to identify and quantitate complex lipid molecular species in mixtures by data-dependent scanning and fragment ion database searching. Journal of the American Society for Mass Spectrometry, 18, 1848–1858.
24. Tautenhahn, R., Cho, K., Uritboonthai, W., Zhu, Z., Patti, G. J., & Siuzdak, G. (2012). An accelerated workflow for untargeted metabolomics using the METLIN database. Nature Biotechnology, 30, 826–828.
25. van den Berg, R. A., Hoefsloot, H. C., Westerhuis, J. A., Smilde, A. K., & van der Werf, M. J. (2006). Centering, scaling, and transformations: Improving the biological information content of metabolomics data. BMC Genomics, 7, 142.
26. Wellner, N., Diep, T. A., Janfelt, C., & Hansen, H. S. (2013). N-acylation of phosphatidylethanolamine and its biological functions in mammals. Biochimica et Biophysica Acta, 1831, 652–662.
27. Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., et al. (2013). HMDB 3.0–The Human Metabolome Database in 2013. Nucleic Acids Research, 41, D801–D807.
28. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: A knowledgebase for the human metabolome. Nucleic Acids Research, 37, D603–D610.
29. Yilmaz, M. T., Kesmen, Z., Baykal, B., Sagdic, O., Kulen, O., Kacar, O., et al. (2013). A novel method to differentiate bovine and porcine gelatins in food products: NanoUPLC-ESI-Q-TOF-MS(E) based data independent acquisition technique to detect marker peptides in gelatin. Food Chemistry, 141, 2450–2458.